TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
GERN

Geron Corporation

Healthcare · Biotechnology

1.30$ +0.0% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Cash Flow

Geron Corporation (GERN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -16 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow GERN
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
-51 -41 -62 -53 -59 -44 -48 -27 -14 -22 -63 -16 -114
0.3 0.2 0.3 0.4 0.2 0.3 0.3 0.3 0.3 0.3 0.3 0.3 1.2
7.6 4.6 5.0 13 6.9 6.8 7.4 -7.4 6.8 7.4 4.9 4.9 24
4.3
-11 8.7 -11 2.7 -38 -23 -35 -19 -2.3 -12 -64 -17 -96
0.2 0.1 0.6 0.2 0.0 0.1 48 0.1 0.1 0.0 0.3 0.2 0.6
-4.7 48 34 -36 -0.6 -104 52 20 13 21 52 8.3 95
29 33 148 17 3.6 166 0.3 1.1 0.5 0.4 2.4 1.4 4.7
-26 40 120 -73 -56 19 4.7 -6.0 0.4 -0.6 -8.7 -6.2 -15
-51 -41 -63 -54 -59 -44 -48 -28 -13 -22 -63 -16 -115

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?